FR Q1 2026 Earnings Massive EPS Beat Surprises Market CEPT Q1 2026 Earnings EPS Surges 96 Above Estimates Amid Investment Gains ArcBest Q1 2026 Earnings EPS Surpasses Estimates on Strong Cost Control Beam Therapeutics Q1 2026 Earnings NarrowerThanExpected Loss Highlights Expense Discipline Lantern Pharma LTRN Q1 2026 Earnings EPS Beats Estimates by 183 Despite Absence of Revenue ThredUp TDUP Q1 2026 Earnings Narrow Loss Beats Estimates but Stock Slips on Revenue Concerns